Standout Papers

Minimum clinically important difference for the COPD Assessment Test: a prospective analysis 2014 2026 2018 2022 456
  1. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis (2014)
    Samantha S.C. Kon, Jane L. Canavan et al. The Lancet Respiratory Medicine

Immediate Impact

57 standout
Sub-graph 1 of 23

Citing Papers

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2025 Standout
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
2 intermediate papers

Works of Jane L. Canavan being referenced

Minimum clinically important difference for the COPD Assessment Test: a prospective analysis
2014 Standout

Author Peers

Author Last Decade Papers Cites
Jane L. Canavan 1595 886 223 294 31 2.2k
Samantha S.C. Kon 1869 1072 202 401 45 2.7k
Claire M. Nolan 1869 1020 217 325 62 2.7k
Nha Voduc 1248 697 121 181 26 1.7k
Eva Farrero 1387 512 110 81 51 2.0k
M.H.G. de Greef 718 773 274 123 58 2.4k
Pamela Berry 2266 940 104 60 26 3.0k
Bronwen Connolly 971 633 62 277 75 2.9k
Amy L. Clark 1188 403 146 73 25 1.6k
Elena Gimeno‐Santos 2038 831 396 83 78 2.6k
Miriam Groenen 1192 624 205 82 21 2.1k

All Works

Loading papers...

Rankless by CCL
2026